Cargando...
Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosis,
BACKGROUND: Evidence on the effectiveness of respiratory syncytial virus (RSV) immunoprophylaxis with palivizumab in children with cystic fibrosis (CF) is lacking. METHODS: We utilized Medicaid Extract files from 27 states from 1999 to 2006 linked to the National Cystic Fibrosis Registry to establis...
Guardado en:
| Publicado en: | Pediatr Pulmonol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7167886/ https://ncbi.nlm.nih.gov/pubmed/23139089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.22711 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|